U.S. Tobacco Stock News

NYSE:NUE
NYSE:NUEMetals and Mining

Is Nucor (NUE) Still Attractive After A 35% One Year Share Price Gain

If you are wondering whether Nucor's share price still reflects good value or is already pricing in a lot of optimism, you are in the right place. Nucor's stock closed at US$176.07, with returns of 0.3% over 7 days, a 2.7% decline over 30 days, 3.9% year to date and 35.1% over 1 year. The 5 year return stands at 182.1% and the 3 year return at 6.1%. Recent headlines around Nucor have mainly focused on its position in the US steel industry and how investors are thinking about its long term...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Is Down 8.8% After Strong Q3, Raised Guidance And Spin-Off Plan - Has The Bull Case Changed?

Modine Manufacturing recently reported stronger-than-expected Q3 FY2026 results, highlighted by robust data center segment performance, raised full-year guidance, and a plan to spin off its Performance Technologies segment to sharpen focus on core thermal management solutions. This combination of better earnings, a clearer focus on higher-growth thermal applications, and a dedicated data center growth target of US$2.00 billion by FY2028 could meaningfully reshape how investors view the...
NYSE:BAX
NYSE:BAXMedical Equipment

Reassessing Baxter International (BAX) Valuation After Recent Share Price Weakness

Why Baxter International (BAX) Is Back on Investors’ Radar Baxter International (BAX) has drawn fresh attention after its shares closed at $19.03, with mixed recent returns across the week, month, and past 3 months prompting investors to reassess the healthcare supplier. See our latest analysis for Baxter International. At a share price of $19.03, Baxter’s recent 7 day share price return of an 8.2% decline and year to date share price return of a 2.4% decline sit against a 1 year total...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

SELLAS Life Sciences (SLS) Is Up 21.8% After REGAL Trial Clears Key Continuation Review - What's Changed

In recent months, SELLAS Life Sciences Group reported encouraging activity for SLS009 in combination with AZA/VEN in relapsed/refractory AML and confirmed that the Independent Data Monitoring Committee recommended the Phase 3 REGAL trial continue without modification, with final analysis expected before year-end. This combination of positive efficacy signals and trial continuity strengthens the clinical credibility of SELLAS’s pipeline in a difficult-to-treat leukemia setting. We’ll now...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Assessing Bitdeer Technologies Group (BTDR) Valuation After Recent Capital Raises And Mixed Q4 Outcomes

Why Bitdeer’s latest capital raise matters for shareholders Bitdeer Technologies Group (BTDR) has just raised fresh capital through a US$43.7 million follow on equity offering, shortly after completing a US$325 million convertible bond issue. This puts its funding decisions in focus for current and prospective shareholders. These back to back transactions give Bitdeer more financial resources to work with. However, they also introduce questions about dilution, future interest costs, and how...
NYSE:DXC
NYSE:DXCIT

Does DXC’s AI-Driven Hogan Overhaul And Margin Focus Change The Bull Case For DXC Technology (DXC)?

DXC Technology recently outlined its renewed vision at the Morgan Stanley Technology, Media & Telecom Conference 2026, emphasizing a dual-track plan to upgrade core IT services and develop AI-enhanced offerings, including a refreshed Hogan core banking platform and a more modular approach to client solutions. The company also highlighted disciplined operational changes, such as exiting lower-margin work, streamlining its workforce, and favoring organic growth and acqui-hires over large...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Did Record ENHANZE Royalties and New Deals Just Shift Halozyme Therapeutics' (HALO) Investment Narrative?

In recent weeks, Halozyme Therapeutics reported record 2025 revenue of about US$1.40 billion, highlighted growing ENHANZE-driven royalties, and outlined progress integrating its Hypercon and Surf Bio acquisitions, while also securing new global collaborations and regulatory approvals for ENHANZE-enabled products. Against this backdrop, CEO Helen Torley’s appearance at the TD Cowen Health Care Conference offers investors fresh context on how Halozyme aims to build on its high-margin,...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Expedia Group (EXPE) Is Up 8.8% After New PredictHQ Demand-Intelligence Partnership - What's Changed

In early March 2026, PredictHQ announced a partnership with Expedia Group to integrate its verified event signals and predictive demand intelligence into Expedia’s Partner Central platform, giving lodging partners direct access to combined forward-looking demand forecasts and traveler insights. A key insight from this collaboration is the projection that traveler spending in North America’s host cities between June and August 2026 could exceed US$8.10 billion, with accommodation spend...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Assessing RadNet (RDNT) Valuation After A Cooldown In Share Price Momentum

Key recent performance context for RadNet RadNet (RDNT) has drawn investor attention after a mixed run in its share price, with gains over the past year and past 3 months contrasted by a decline over the past month and past 3 months. This recent volatility, alongside annual revenue growth of 12.57% and net income growth of 63.37%, is prompting closer scrutiny of how the company’s imaging and digital health businesses may be reflected in its current valuation. See our latest analysis for...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story

Omnicell, ticker NasdaqGS:OMCL, is shifting its focus toward a software and services led model. The company recently acquired ANiGENT to deepen its capabilities in drug diversion detection within healthcare settings. This move marks a meaningful step in Omnicell's transition from a hardware vendor to a Healthcare IT company. Omnicell's pivot comes after a mixed share price record, with the stock at $41.53 and a value score of 4. The shares show a 9.8% gain over the past year, while longer...
NYSE:LC
NYSE:LCConsumer Finance

Assessing LendingClub (LC) Valuation After Its Transition To A Fully Regulated US Bank

LendingClub (LC) is drawing fresh attention after completing its shift to a fully regulated US bank, with recent earnings highlighting stabilizing margins, higher capital levels, and tighter loan origination focused on credit quality. See our latest analysis for LendingClub. The completed bank transition and recent earnings sit against a mixed trading backdrop, with a 5.05% 1 day share price return to $15.61 following weaker 30 and 90 day share price returns. At the same time, the 1 year...
NYSE:NOG
NYSE:NOGOil and Gas

A Look At Northern Oil And Gas (NOG) Valuation After Q4 Loss And Large Impairment Charge

Northern Oil and Gas (NOG) just released its fourth quarter and full year 2025 update, combining a large US$268,497,000 impairment charge with new 2026 production guidance, refreshed credit capacity, ongoing buybacks, and a maintained dividend. See our latest analysis for Northern Oil and Gas. That mix of a US$268.5m impairment, higher 2025 revenue and fresh 2026 production guidance has arrived alongside a 28.9% year to date share price return and a 1 year total shareholder return of 9.9%...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Tower Semiconductor Taps Silicon Photonics For AI Networking And Quantum Upside

Tower Semiconductor (NasdaqGS:TSEM) is moving its partnership with Salience Labs into pre-production to manufacture PIC based OCS for AI data center infrastructure. The joint OCS solution is scheduled to be showcased at the OFC 2026 Conference, giving early visibility to potential customers in high performance AI networking. Tower is also expanding its work with Xanadu to support manufacturing for fault tolerant quantum computing hardware on its silicon photonics platform. Tower...
NYSE:NE
NYSE:NEEnergy Services

Assessing Noble (NE) Valuation After Strong Recent Share Price Momentum

Why Noble Is On Investors' Radar Noble (NE), an offshore drilling contractor headquartered in Houston, has drawn attention after a strong stock move over the past month. This has prompted investors to recheck how its current valuation lines up with its fundamentals. See our latest analysis for Noble. Beyond the recent move, Noble’s 30 day share price return of 27.28% and year to date share price return of 58% sit alongside a 1 year total shareholder return of 116.6%. This indicates strong...
NasdaqGS:CALM
NasdaqGS:CALMFood

Cal Maine Expands Indiana Egg Operations As Valuation Gap Draws Attention

Cal-Maine Foods (NasdaqGS:CALM) has completed the acquisition of Creighton Brothers LLC and Crystal Lake LLC. The deal expands Cal-Maine's shell egg, egg products, and prepared foods operations into Indiana. The transaction adds production capacity and internal supply chain resources across conventional and specialty egg categories. For you as an investor, this move adds another piece to the Cal-Maine story as the company increases its presence across the U.S. egg market. NasdaqGS:CALM is a...
NYSE:IQV
NYSE:IQVLife Sciences

Why IQVIA (IQV) Is Up 9.9% After Mixed Q4 Results and AI-Linked Outlook Reset

IQVIA Holdings’ recent fourth-quarter results showed 10.3% revenue growth, a larger R&D backlog, and a strong book-to-bill ratio, prompting several analysts to reaffirm positive ratings while adjusting their expectations due to AI-related challenges and business re-segmentation. At the same time, rising analyst attention, ongoing executive conference appearances, and insider share sales alongside higher estimated 2025 CEO compensation highlight how IQVIA’s leadership, incentives, and capital...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Sizing Up Ondas (ONDS) After Its 10x One Year Share Price Surge

If you are wondering whether Ondas is still priced attractively after its recent run, this article will help you size up where the stock stands today. The share price closed at US$10.51, with a small 7 day gain of 2.0%, a 30 day return of 1.2% decline, a year to date return of 4.6% decline, and a very large 1 year return that is well over 10x. That kind of move tends to follow meaningful company updates, partnerships, financings, or regulatory milestones that change how investors think about...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence Shelf Registration Highlights Role In Expanding Semiconductor IP Market

Cadence Design Systems (NasdaqGS:CDNS) has filed a significant shelf registration, giving it the flexibility to issue securities in the future. The company is being highlighted as a key player in the expanding semiconductor IP market, where demand for licensed chip designs is increasing. These developments are drawing investor attention to Cadence's capital options and its role in a growing segment of the semiconductor ecosystem. Cadence Design Systems develops software and intellectual...
NYSE:O
NYSE:ORetail REITs

Does Realty Income’s (O) Guidance Cut and Leadership Change Hint at a Shifting Income Strategy?

In late February 2026, Realty Income reported higher quarterly and full-year 2025 revenue and net income, issued 2026 earnings guidance of US$1.65–US$1.69 per share, and subsequently saw its stock rating cut to Hold from Buy by Freedom Capital Markets. Shortly after these updates, Realty Income also announced the planned departure of its Chief Legal Officer, underscoring both leadership transition and investor focus on how management will execute against modest 2026 guidance. We’ll now...
NYSE:TREX
NYSE:TREXBuilding

Assessing Trex Company (TREX) Valuation After Mixed Share Performance And Modest Undervaluation Estimate

What recent performance says about Trex Company (TREX) With no single headline event driving Trex Company (TREX) today, the stock’s recent performance is doing most of the talking for investors tracking entry or exit points. Over the past month the share price shows a return of about a 3% decline, while the past 3 months reflect a gain of roughly 17%. On a 1 year view, the stock is down around 31%, and longer 3 year and 5 year total returns are also negative. That mixed record contrasts with...
NYSE:EPRT
NYSE:EPRTREITs

Is Essential Properties Realty Trust (EPRT) Still Attractive After Recent Share Price Gains

If you are wondering whether Essential Properties Realty Trust is reasonably priced or starting to look expensive, you are not alone. The stock last closed at US$34.57, with returns of 3.4% over 7 days, 14.8% over 30 days, 15.0% year to date and 12.0% over the past year, which naturally raises questions about what is already reflected in the price. Recent attention on Essential Properties Realty Trust has largely focused on its role as a net lease REIT and how that business model fits into...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

A Look At The RealReal (REAL) Valuation After Strong Q4 Results And 2026 Growth Guidance

The RealReal (REAL) just paired a strong fourth quarter with fresh 2026 guidance, reporting higher year over year revenue, narrower net losses and its first full year of consistently positive adjusted EBITDA. See our latest analysis for RealReal. After this earnings and guidance update, RealReal’s latest share price of $12.13 comes after mixed short term moves, with a 4.30% 1 day share price return but a 17.54% 30 day share price decline, while the 1 year total shareholder return of 111.88%...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Is It Too Late To Consider Brookfield Infrastructure Partners (NYSE:BIP) After 35% One Year Rally?

If you are wondering whether Brookfield Infrastructure Partners is still good value at around US$38.94, the key question is how its current price lines up with what the underlying business might be worth. The unit price has been relatively firm recently, with a 6.3% move over the last 30 days and a 13.5% return year to date, while the 1 year return sits at 35.5% and the 5 year return at 39.8%. These moves sit against an ongoing stream of news about global infrastructure demand, financing...
NYSE:STVN
NYSE:STVNLife Sciences

Stevanato Group (NYSE:STVN) Margin Improvement To 12% Tests Bullish Earnings Narratives

Stevanato Group FY 2025 Earnings Snapshot Stevanato Group (NYSE:STVN) has put another solid quarter on the board for FY 2025, with Q3 revenue of €303.2 million and basic EPS of €0.13, alongside trailing twelve month EPS of €0.52 on €1.17 billion of revenue, capped by 22.6% earnings growth over the past year. The company has seen revenue move from €259.6 million in Q2 2024 to €303.2 million in Q3 2025, while quarterly EPS has ranged between €0.08 and €0.18 over that period, setting up a...